CM
ASMB icon

Caption Management’s Assembly Biosciences ASMB Stock Holding History

Caption Management’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-18,750
Closed -$783K – 1577
2021
Q3 		$783K Sell
18,750
-2,083
-10% -$87.3K 0.01% 1094
2021
Q2 		$970K Buy
+20,833
New +$1.03M 0.01% 902

Other funds holding ASMB

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Caption Management's ASMB Position: Q1 2026 in Review

Caption Management reduced its Assembly Biosciences (ASMB) stake by 23% in Q1 2026, selling an estimated $706K and leaving 81,841 shares worth $2.27M. The position accounts for 0.01% of the portfolio, ranked #789.

Caption Management first reported a position in ASMB in Q2 2019 and has held it in 8 quarters since. The position peaked at $3.63M in Q4 2025. 75 funds tracked by Wall St. Rank hold ASMB as of Q1 2026.

  • Caption Management held 81,841 shares of Assembly Biosciences worth $2.27M as of Q1 2026.
  • Caption Management sold 24,750 Assembly Biosciences shares in Q1 2026, an estimated $706K.
  • Assembly Biosciences made up 0.01% of Caption Management's portfolio in Q1 2026, its #789 holding.
  • Caption Management first reported a position in Assembly Biosciences in Q2 2019 and has held it in 8 quarters since.
  • Caption Management's Assembly Biosciences position peaked at $3.63M in Q4 2025.
  • 75 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.